Skip to main content
. 2017 Oct 26;15(10):e05017. doi: 10.2903/j.efsa.2017.5017

Figure C.3.

Figure C.3

Secondary indicator: Proportion of total hospital AMC that are glycopeptides, 3rd‐ and 4th‐generation cephalosporins, monobactams, carbapenems, fluoroquinolones, polymyxins, piperacillin and enzyme inhibitor, linezolid, tedizolid and daptomycin (DDD per 1,000 inhabitants and per day) (ESAC‐Net, 2015)